Zeotech Balance Sheet Health

Financial Health criteria checks 4/6

Zeotech has a total shareholder equity of A$11.5M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$12.8M and A$1.3M respectively.

Key information

Debt to equity ratio

AU$0

Debt

Interest coverage ratio	n/a
Cash	AU$2.27m
Equity	AU$11.54m
Total liabilities	AU$1.30m
Total assets	AU$12.84m

Recent financial health updates

Recent updates

Here's Why We're Not Too Worried About Zeotech's (ASX:ZEO) Cash Burn Situation

Aug 29

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

May 07

Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?

Jan 20

Increases to CEO Compensation Might Be Put On Hold For Now at Zeotech Limited (ASX:ZEO)

Nov 21

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Mar 22

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Oct 27

We Think Zeotech (ASX:ZEO) Can Afford To Drive Business Growth

Apr 19

Trade Alert: Anthony Sheridan At Zeotech Limited (ASX:ZEO), Has Just Spent AU$780k Buying 8.8% More Shares

Feb 18

Here's What Zeotech Limited's (ASX:ZEO) Shareholder Ownership Structure Looks Like

Jan 25

Financial Position Analysis

Short Term Liabilities: ZEO's short term assets (A$2.3M) exceed its short term liabilities (A$1.1M).

Long Term Liabilities: ZEO's short term assets (A$2.3M) exceed its long term liabilities (A$248.2K).

Debt to Equity History and Analysis

Debt Level: ZEO is debt free.

Reducing Debt: ZEO had no debt 5 years ago.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ZEO has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ZEO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 19% each year

Zeotech Balance Sheet Health

Financial Health criteria checks 4/6

Key information

Recent financial health updates

Here's Why We're Not Too Worried About Zeotech's (ASX:ZEO) Cash Burn Situation

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Zeotech Limited to Be Deleted from Other OTC

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Recent updates

Zeotech Limited, Annual General Meeting, Nov 22, 2024

Full year 2024 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2023)

Here's Why We're Not Too Worried About Zeotech's (ASX:ZEO) Cash Burn Situation

Zeotech Limited Appoints Scott Burkhart as Chief Operating Officer

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

MD & Director exercised options and sold AU$232k worth of stock

First half 2024 earnings released: AU$0.002 loss per share (vs AU$0 in 1H 2023)

New major risk - Financial position

New major risk - Share price stability

Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?

Insider recently sold AU$82k worth of stock

New minor risk - Share price stability

Zeotech Limited Announces CEO Changes, Anticipates to Occur from 1 November 2023

Zeotech Limited, Annual General Meeting, Nov 23, 2023

Full year 2023 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2022)

New minor risk - Financial data availability

MD, COO & Director recently sold AU$135k worth of stock

First half 2023 earnings released: EPS: AU$0 (vs AU$0.001 loss in 1H 2022)

Zeotech Limited Appoints Alister Morrison as Chief Executive Officer, Effective 13 March 2023

MD, COO & Director exercised options to buy AU$490k worth of stock.

Zeotech Limited Announces Successful Completion of Pilot Program Accelerates Technology Development

Increases to CEO Compensation Might Be Put On Hold For Now at Zeotech Limited (ASX:ZEO)

No independent directors

Zeotech Limited, Annual General Meeting, Nov 28, 2022

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2021)

Zeotech Limited, Annual General Meeting, Aug 31, 2022

Zeotech Limited Achieves Successful Continuous Closed- Loop Circuit, Utilising Lithium Process By-Product Feedstock (Leached Spodumene) to Produce Pure Linde Type A Manufactured Zeolite

No independent directors

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Zeotech Limited to Be Deleted from Other OTC

Zeotech Limited Announces Pilot Program Update

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Full year 2021 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2020)

Zeotech Limited announced that it expects to receive AUD 3.7005 million in funding

We Think Zeotech (ASX:ZEO) Can Afford To Drive Business Growth

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2020)

Trade Alert: Anthony Sheridan At Zeotech Limited (ASX:ZEO), Has Just Spent AU$780k Buying 8.8% More Shares

Zeotech Limited Pilot Plant Program Commences

Zeotech Limited Executes Research Agreement with UQ to Evaluate Carbon Capture Using Synthetic Zeolites

Here's What Zeotech Limited's (ASX:ZEO) Shareholder Ownership Structure Looks Like

Zeotech Limited Announces resignation of John Goody as Non-Executive Director

Metalsearch Limited Announces Participating in Agronomic Trials to Evaluate the Performance of Synthetic Zeolites Across A Range of Agricultural Applications

Full year earnings released

Metalsearch Limited announced that it has received AUD 1.6575 million in funding

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Cash Runway Analysis

Discover healthy companies